Following the AT classification system, we categorized individuals into three groups: biomarker negative individuals (A−T−), individuals in early AD stages: amyloid positivity but tau negativity (A+T−), and full biomarkers positive individuals (A+T+), which cover the entire AD continuum. Here, MAPT is linked to Alzheimer disease.